Leo Mavely

Leo Mavely is the current president of Advamedica. Prior to this, they worked at Axio Biosolutions Private Limited and NirmaLabs. At NirmaLabs, they were an incubatee and was responsible for developing the core technology of Project-1006 from concept to product stage. On successful completion of the incubation project, it was then spun out as a privately held company which later attracted angel funding and received government grant from DST. Some of the milestones achieved during their tenure include screened more than 100 unmet healthcare needs through a systematic process and selected 2 viable projects, got Department of Science and Technology to fund the project for early product development, proof-of-concept was established and completed incubation successfully, and the project metamorphosed into a private limited company with investor backing.

Leo Mavely has a B. Tech in Applied Bioengineering from MDU, Rohtak, and a Dip. in Managing Technology Ventures from NirmaLabs. Leo is currently pursuing their schooling from Don Bosco High School, SN HSS.

Some individuals on their team include Maria Samuel - Director, Quality & Regulatory, Samantha Labanti - Director, Clinical Marketing, and Oscar Rospigliosi - SVP, North America & International.